Palvella Therapeutics (PVLA) Short-term Investments (2017 - 2026)
Palvella Therapeutics (PVLA) posted quarterly Short-term Investments of $55.5 million for Q1 2026, up 518.27% quarter-over-quarter from $9.0 million in Q4 2023.
Palvella Therapeutics (PVLA) Short-term Investments (2017 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Short-term Investments for 7 consecutive years, with $55.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Short-term Investments changed N/A year-over-year to $55.5 million; the TTM figure through Mar 2026 stood at $55.5 million (changed N/A YoY), while the FY2023 annual figure was $9.0 million, down 56.32% from the prior year.
- Short-term Investments advanced to $55.5 million in Q1 2026 per PVLA's latest filing, from $9.0 million in the prior quarter.
- Across five years, Short-term Investments topped out at $55.5 million in Q1 2026 and bottomed at $8.6 million in Q1 2023.
- Historically, Short-term Investments has averaged $20.0 million across 3 years, with a median of $16.5 million in 2022.
- On a YoY basis, Short-term Investments climbed as much as 44.32% in 2023 and fell as far as 62.75% in 2023.
- Palvella Therapeutics' Short-term Investments stood at $20.5 million in 2022, then plunged by 56.32% to $9.0 million in 2023, then soared by 518.27% to $55.5 million in 2026.
- Business Quant data shows PVLA's Short-term Investments at $55.5 million in Q1 2026, $9.0 million in Q4 2023, and $11.9 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.78 Mn |
| Mar 31, 2026 | 55.46 Mn |
| Dec 31, 2023 | 8.97 Mn |
| Sep 30, 2023 | 11.92 Mn |
| Jun 30, 2023 | 9.94 Mn |
| Mar 31, 2023 | 8.64 Mn |
| Dec 31, 2022 | 20.53 Mn |
| Sep 30, 2022 | 21.40 Mn |
| Jun 30, 2022 | 26.68 Mn |
| Mar 31, 2022 | 16.53 Mn |
| Sep 30, 2020 | 15.75 Mn |
| Jun 30, 2020 | 32.91 Mn |
| Mar 31, 2020 | 39.33 Mn |
| Dec 31, 2019 | 41.89 Mn |
| Sep 30, 2019 | 40.18 Mn |
| Jun 30, 2019 | 44.78 Mn |
| Mar 31, 2019 | 58.69 Mn |
| Dec 31, 2018 | 53.24 Mn |
| Sep 30, 2018 | 47.82 Mn |
| Jun 30, 2018 | 100.40 Mn |